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Introduction {#jcsm12154-sec-0005}
============

Ageing can lead to unfavourable changes in body composition, such as bone and muscle loss, and fat gain, raising the risk of osteoporosis, sarcopenia, and obesity in mid‐ and late‐life.[1](#jcsm12154-bib-0001){ref-type="ref"}, [2](#jcsm12154-bib-0002){ref-type="ref"}, [3](#jcsm12154-bib-0003){ref-type="ref"} Bone, muscle, and adipose tissues are inter‐connected.[4](#jcsm12154-bib-0004){ref-type="ref"} The mechanical interactions between bone and muscle are well established, and a growing body of research suggests a potential cross‐talk between bone and muscle.[5](#jcsm12154-bib-0005){ref-type="ref"} The increase in adiposity also exacerbates the loss of bone and muscle mass.[4](#jcsm12154-bib-0004){ref-type="ref"} A combination of adverse interrelationships in body composition is hypothesized to manifest in osteosarcopenic obesity, a term coined to depict a concurrent occurrence of the three phenotypes, osteopenia/osteoporosis, sarcopenia, and obesity.[4](#jcsm12154-bib-0004){ref-type="ref"} Osteosarcopenic obesity may lead to functional impairment and increase the risk of falls, fractures, and morbidity.[6](#jcsm12154-bib-0006){ref-type="ref"}

Vitamin D is known to be vital in sustaining musculoskeletal functions, with vitamin D deficiency causing muscle weakness and decreased bone mineral density.[7](#jcsm12154-bib-0007){ref-type="ref"} Vitamin D also appears to have pleiotropic effects by inhibiting adipogenesis and modulating inflammatory response on adipose tissues, with accumulating evidence linking low levels of vitamin D to obesity.[8](#jcsm12154-bib-0008){ref-type="ref"} Vitamin D inadequacy is highly prevalent, with vitamin D deficiency or insufficiency estimated to affect one billion people worldwide.[7](#jcsm12154-bib-0007){ref-type="ref"}, [9](#jcsm12154-bib-0009){ref-type="ref"}

Previous studies have indicated a significant association between serum vitamin D and individual components of abnormal body composition, manifesting as osteoporosis, sarcopenia, and obesity.[10](#jcsm12154-bib-0010){ref-type="ref"}, [11](#jcsm12154-bib-0011){ref-type="ref"}, [12](#jcsm12154-bib-0012){ref-type="ref"}, [13](#jcsm12154-bib-0013){ref-type="ref"}, [14](#jcsm12154-bib-0014){ref-type="ref"}, [15](#jcsm12154-bib-0015){ref-type="ref"}, [16](#jcsm12154-bib-0016){ref-type="ref"} Besides vitamin D having individual protective effects on either bone or muscle mass and modulating body fat accumulation,[7](#jcsm12154-bib-0007){ref-type="ref"}, [8](#jcsm12154-bib-0008){ref-type="ref"}, [17](#jcsm12154-bib-0017){ref-type="ref"}, [18](#jcsm12154-bib-0018){ref-type="ref"}, [19](#jcsm12154-bib-0019){ref-type="ref"} vitamin D as a single factor displaying combined effects, such as on both bone and muscle mass, has been suggested.[12](#jcsm12154-bib-0012){ref-type="ref"} However, few studies have examined the relationship between serum vitamin D with combined abnormalities in body composition.[20](#jcsm12154-bib-0020){ref-type="ref"}, [21](#jcsm12154-bib-0021){ref-type="ref"}, [22](#jcsm12154-bib-0022){ref-type="ref"}, [23](#jcsm12154-bib-0023){ref-type="ref"} Moreover, there is no study that has investigated its association with osteosarcopenic obesity.

The aim of this study was to examine the association of 25‐hydroxyvitamin D (abbreviated 25(OH)D) level with a combined adverse body composition (bone, muscle, and fat) in a representative sample of middle‐aged and older people living in the community.

Subjects and methods {#jcsm12154-sec-0006}
====================

Study population {#jcsm12154-sec-0007}
----------------

Data are from the Fourth and Fifth Korea National Health and Nutrition Examination Survey (KNHANES IV--V) in 2008--2010, conducted by the Korea Centers for Disease Control and Prevention (KCDC). Details of the survey design are described elsewhere.[24](#jcsm12154-bib-0024){ref-type="ref"} KNHANES IV--V employs a multistage stratified cluster sampling for the selection of household units of non‐institutionalized residents. The study protocols were approved by the Institutional Review Board of the KCDC. Written informed consent forms were obtained from all participants.

KNHANES IV--V consists of the health interview survey, health examination, and nutritional assessment. Among the 6056 aged ≥ 50 y who completed the three evaluations, those with implausibly high laboratory data (*n* = 2) and low or high daily energy intake (\<800 kcal/d or \> 4000 kcal/d for men, \<500 kcal/d or \>3500 kcal/d for women) (86 men and 60 women) were excluded. The sample used in the final analysis comprised of 2485 men and 3423 women.

Measurements {#jcsm12154-sec-0008}
------------

To measure the serum 25(OH)D level, blood samples of individual subjects were collected during the survey after an overnight fast and analysed within 24 h after transport. A gamma counter (1470 WIZARD; Perkin‐Elmer, Turku, Finland) with radioimmunoassay (DiaSorin; Stillwater, MN, USA) was used to assess serum 25(OH)D concentrations. Inter‐assay coefficients of variation varied from 8.6% to 12.5%.[25](#jcsm12154-bib-0025){ref-type="ref"} Subjects were classified by tertiles of serum vitamin D values. A serum 25(OH)D level less than 20 ng/mL was defined to indicate vitamin D deficiency.[26](#jcsm12154-bib-0026){ref-type="ref"}

Body composition was measured with dual‐energy x‐ray absorptiometry (Discovery‐W, Hologic Inc., Waltham, MA, USA). Based on the recommendations of the International Society for Clinical Densitometry in 2007,[27](#jcsm12154-bib-0027){ref-type="ref"} bone mineral density measurements were performed. Low bone mass was defined to include both osteopenia (*T*‐score between −1.0 and −2.5) and osteoporosis (*T*‐score −2.5 and below), using the World Health Organization criteria[28](#jcsm12154-bib-0028){ref-type="ref"} calculated from the Asian reference data. Appendicular skeletal muscle mass (ASM), the sum of lean soft‐tissue mass in both extremities,[29](#jcsm12154-bib-0029){ref-type="ref"} was measured. Low muscle mass was defined as ASM more than 1 SD below the gender‐specific mean of the young healthy reference group.[30](#jcsm12154-bib-0030){ref-type="ref"} Obesity was defined as the upper 40% of body fat by gender.[31](#jcsm12154-bib-0031){ref-type="ref"} The number of adverse body composition was categorized as 0 (normal; without low bone mass, low muscle mass, or obesity), 1 (having one of the components), 2 (having two of the components), and 3 (osteosarcopenic obesity; having all three components).

Covariates {#jcsm12154-sec-0009}
----------

Sociodemographic characteristics included age, education level (elementary school or lower vs. higher than elementary school), and equivalent household income (monthly household income divided by the square root of the number of household members by gender and 5‐year age group). Smoking status was classified as none, past, or current. Alcohol consumption was dichotomized as ≤1 drink/d vs. \>1 drink/d. Physical activity assessed participation in recommended levels (≥150 min/week of moderate‐intensity and/or ≥ 75 min/week of vigorous‐intensity) of aerobic physical activity.[32](#jcsm12154-bib-0032){ref-type="ref"} Sunlight exposure (\<5 h/d vs. ≥ 5 h/d) and dietary supplement use were also obtained by self‐report. For women, menopausal status was reported. Laboratory data included systolic blood pressure (SBP), diastolic BP (DBP), fasting blood sugar (FBS), total cholesterol, high density lipoprotein cholesterol (HDL‐C), triglyceride, aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, and parathyroid hormone (PTH). Homeostasis model assessment of insulin resistance (HOMA‐IR) was defined as fasting plasma glucose (mg/dL) multiplied by fasting insulin (microIU/mL) divided by 22.5.[33](#jcsm12154-bib-0033){ref-type="ref"} The 24‐h dietary recall and food frequency questionnaire were applied to measure dietary intakes. Frequency of food group consumption (meats, egg, fish, mushrooms, and milk) and nutrient intake (energy, protein, and calcium) was derived from dietary intakes.

Statistical analyses {#jcsm12154-sec-0010}
--------------------

The characteristics of the study sample were presented as mean and standard deviation (SD), or percentages. The relationship between sample characteristics and the number of adverse body composition was analysed using the analysis of variance (ANOVA) and chi‐square tests. Potential laboratory confounders with *P* \< 0.20 in their associations with both serum vitamin D and body composition in the bivariate analyses were adjusted in the final model. Using multinomial logistic regression analysis, risks of adverse body composition, with tertiles or deficiency of serum vitamin D levels, were shown as odds ratios (OR) and 95% confidence intervals (CI), adjusting for covariates. All analyses were conducted separately by gender, using IBM SPSS Statistics 22.0 (SPSS, International Business Machines Corp., Armonk, NY). The complex sampling weights were applied in all analyses.

Results {#jcsm12154-sec-0011}
=======

Among men, for the number of adverse body composition, 26.3% had none, 38.9% had one, 21.4% had two, and 13.5% had all three (osteosarcopenic obesity). In women, it was 10.2%, 46.0%, 18.8%, and 25.0%, respectively. The prevalence of vitamin D deficiency was 45.5% in men and 63.4% in women.

The sample characteristics are shown in *Table* [1](#jcsm12154-tbl-0001){ref-type="table-wrap"}. The mean age was higher in women than men. The education levels, rates of current smoking, alcohol consumption, participation in recommended levels of physical activity, and sunlight exposure were higher among men than women. Compared with men, more women used dietary supplements and most of the women were post‐menopause. The laboratory data, frequency of food group consumption, and nutrient intakes were higher in men, but PTH levels and frequency of milk consumption were higher in women.

###### 

Characteristics of study subjects[a](#jcsm12154-note-0001){ref-type="fn"}

  　                                                                       Men (*n* = 2485)   Women (*n* = 3423)                                                             Men (*n* = 2485)   Women (*n* = 3423)
  ------------------------------------------------------------------------ ------------------ -------------------- --------------------------------------------------------- ------------------ --------------------
  General characteristics                                                                                          Laboratory data[d](#jcsm12154-note-0004){ref-type="fn"}                      
  Age (y)                                                                  60.7 ± 8.4         61.7 ± 8.9           SBP (mmHg)                                                123.8 ± 17.1       125.1 ± 18.1
  Education level                                                                                                  DBP (mmHg)                                                77.8 ± 10.7        76.5 ± 10.1
  ≤Elementary school                                                       31.0               60.0                 FBS (mg/dL)                                               105.3 ± 27.7       101.3 ± 24.3
  \>Elementary school                                                      69.0               40.0                 HOMA‐IR                                                   2.6 ± 1.7          2.7 ± 2.2
  Quartiles of equivalent income[b](#jcsm12154-note-0002){ref-type="fn"}                                           Total cholesterol (mg/dL)                                 187.7 ± 37.0       201.3 ± 36.2
  1 (lowest)                                                               23.1               23.8                 HDL‐C (mg/dL)                                             44.6 ± 10.6        48.4 ± 10.9
  2                                                                        25.9               23.6                 Triglyceride (mg/dL)                                      162.0 ± 119.5      138.2 ± 86.7
  3                                                                        24.0               26.4                 AST (IU/L)                                                26.0 ± 15.4        22.9 ± 9.2
  4 (highest)                                                              27.0               26.2                 ALT (IU/L)                                                24.6 ± 14.6        20.2 ± 11.9
  Smoking                                                                                                          Creatinine (mg/dL)                                        1.0 ± 0.2          0.7 ± 0.2
  Nonsmoker                                                                16.4               92.0                 PTH (pg/mL)                                               65.0 ± 25.2        67.9 ± 30.6
  Past smoker                                                              48.7               3.5                  25(OH)D (ng/mL)                                           21.5 ± 7.3         18.6 ± 7.0
  Current smoker                                                           34.9               4.5                  Frequency of food group consumption                                          
  Alcohol consumption                                                                                              Meats (times/wk)                                          1.5 ± 1.3          1.2 ± 1.5
  ≤1 drink/d                                                               79.1               96.2                 Egg (times/wk)                                            1.9 ± 1.9          1.7 ± 1.9
  \>1 drinks/d                                                             20.9               3.8                  Fish (times/wk)                                           4.6 ± 3.9          4.4 ± 4.0
  Recommended level of exercise[c](#jcsm12154-note-0003){ref-type="fn"}    45.0               37.5                 Mushrooms (times/wk)                                      1.2 ± 1.6          1.1 ± 1.5
  Sunlight exposure                                                                                                Milk (times/wk)                                           1.7 ± 2.5          2.1 ± 3.0
  \<5 h/d                                                                  64.0               78.5                 Nutrient intake                                                              
  ≥5 h/d                                                                   36.0               21.5                 Energy (kcal/d)                                           2111.1 ± 639.9     1570.3 ± 537.0
  Dietary supplement use (yes)                                             33.0               48.3                 Protein (g/d)                                             74.0 ± 30.6        53.0 ± 24.9
  Menopause (yes)                                                                             91.6                 Calcium (mg/d)                                            556.4 ± 344.3      435.3 ± 399.7

Values are mean ± SD, or percentage.

Monthly household income/√number of household members according to sex and 5 year age group.

≥150 min/wk moderate‐intensity and/or ≥ 75 min/wk vigorous‐intensity aerobic physical activity.

ALT, alanine aminotransferase; AST, aspartate aminotransferase; DBP, diastolic blood pressure; FBS, fasting blood sugar; HDL‐C, high density lipoprotein cholesterol; HOMA‐IR, insulin resistance assessed by homeostasis model assessment; PTH, parathyroid hormone; SBP, systolic blood pressure; 25(OH)D, 25‐hydroxyvitamin D.

In men, those having a higher number of adverse body composition tended to be older, less educated, and less likely to consume alcohol, participate in recommended levels of physical activity, and to have shorter exposure to daily sunlight. Laboratory data were significantly associated with the number of adverse body composition, with those having a higher number of adverse body composition exhibiting lower nutrient intakes (*Table* [2](#jcsm12154-tbl-0002){ref-type="table-wrap"}). In women, with an increasing number of adverse body composition, participants tended to be older, less educated, current smokers, and to report less frequent alcohol consumption, lower amounts of physical activity, shorter duration of daily sunlight exposure, and no dietary supplement use, with a higher percentage in post‐menopause. Laboratory data were significantly associated with the number of adverse body composition, and there was a tendency of less frequent consumption of fish, mushrooms, milk, energy, and protein for those with more adverse body composition (*Table* [3](#jcsm12154-tbl-0003){ref-type="table-wrap"}).

###### 

Relationship between the number of adverse body composition[a](#jcsm12154-note-0005){ref-type="fn"} and subject characteristics in men[b](#jcsm12154-note-0006){ref-type="fn"}

                                                                                     Men (*n* = 2485)                                                       
  ---------------------------------------------------------------------------------- ------------------ ----------------- ---------------- ---------------- ---------
  General characteristics                                                                                                                                   
  Age (y)                                                                            58.0 ± 6.7         60.9 ± 8.5        61.6 ± 8.4       63.9 ± 9.4       \<0.001
  Education level (\> elementary school)                                             75.5               64.6              70.7             66.1             0.002
  Quartiles of equivalent income[d](#jcsm12154-note-0008){ref-type="fn"} (highest)   31.0               24.9              28.6             22.5             0.37
  Current smoker                                                                     39.3               35.5              30.5             31.7             0.13
  Alcohol consumption (\> 1 drinks/d)                                                19.6               23.7              20.9             14.9             0.04
  Recommended level of exercise[e](#jcsm12154-note-0009){ref-type="fn"} (yes)        52.4               46.1              42.1             31.6             \<0.001
  Sunlight exposure (≥ 5 h/d)                                                        37.9               39.4              34.1             25.5             0.003
  Dietary supplement use (yes)                                                       32.7               32.1              37.8             28.3             0.11
  Laboratory data[f](#jcsm12154-note-0010){ref-type="fn"}                                                                                                   
  SBP (mmHg)                                                                         122.3 ± 17.4       123.1 ± 17.4      125.1 ± 16.0     126.5 ± 17.0     0.002
  DBP (mmHg)                                                                         77.7 ± 10.8        77.4 ± 11.0       78.8 ± 10.2      77.7 ± 10.3      0.30
  FBS (mg/dL)                                                                        106.4 ± 29.9       101.9 ± 24.8      108\. 6 ± 30.8   108.0 ± 24.6     \<0.001
  HOMA‐IR                                                                            2.4 ± 1.3          2.3 ± 1.5         3.1 ± 2.2        3.1 ± 2.0        \<0.001
  Total cholesterol (mg/dL)                                                          189.0 ± 36.9       185.8 ± 36.6      189.1 ± 38.3     188.3 ± 35.8     0.40
  HDL‐C (mg/dL)                                                                      45.3 ± 10.7        45.9 ± 10.8       42.8 ± 9.8       42.2 ± 10.0      \<0.001
  Triglyceride (mg/dL)                                                               153.7 ± 117.2      150\. 8 ± 112.0   184.4 ± 125.8    175.0 ± 128.2    \<0.001
  AST (IU/L)                                                                         25.0 ± 12.5        26.4 ± 16.1       27.2 ± 19.8      25.2 ± 9.3       0.07
  ALT (IU/L)                                                                         23.5 ± 12.8        23.5 ± 13.5       27.8 ± 18.1      24.9 ± 14.3      \<0.001
  Creatinine (mg/dL)                                                                 1.0 ± 0.2          0.9 ± 0.1         1.0 ± 0.2        1.0 ± 0.3        \<0.001
  PTH (pg/mL)                                                                        62.6 ± 22.7        63.4 ± 23.6       68.8 ± 28.4      68.7 ± 27.3      \<0.001
  Frequency of food group consumption                                                                                                                       
  Meats (times/wk)                                                                   1.6 ± 1.3          1.5 ± 1.3         1.7 ± 1.5        1.4 ± 1.2        0.13
  Egg (times/wk)                                                                     2.1 ± 2.0          1.8 ± 1.8         2.0 ± 2.1        1.9 ± 1.9        0.12
  Fish (times/wk)                                                                    4.5 ± 3.8          4.7 ± 4.0         4.7 ± 3.7        4.1 ± 3.9        0.15
  Mushrooms (times/wk)                                                               1.3 ± 1.5          1.3 ± 1.7         1.2 ± 1.4        1.1 ± 1.3        0.40
  Milk (times/wk)                                                                    1.8 ± 2.5          1.7 ± 2.7         1.5 ± 2.4        1.4 ± 2.5        0.15
  Nutrient intake                                                                                                                                           
  Energy (kcal/d)                                                                    2235.6 ± 653.1     2102.9 ± 627.2    2067.5 ± 649.3   1961.4 ± 589.6   \<0.001
  Protein (g/d)                                                                      79.0 ± 30.3        72.4 ± 29.7       73.5 ± 31.6      69.6 ± 31.0      0.001
  Calcium (mg/d)                                                                     600.0 ± 370.3      555.8 ± 332.7     540.0 ± 309.8    499.3 ± 365.5    0.006

Multiple adverse body composition: number of osteopenia/osteoporosis, muscle mass loss, or obesity.

Values are mean ± SD, or percentage.

Analysis of variance (ANOVA) for continuous variables and chi‐square test for categorical variables.

Monthly household income/√number of household members according to sex and 5‐year age group.

≥ 150 min/wk moderate‐intensity and/or ≥75 min/wk vigorous‐intensity aerobic physical activity.

ALT, alanine aminotransferase; AST, aspartate aminotransferase; DBP, diastolic blood pressure; FBS, fasting blood sugar; HDL‐C, high density lipoprotein cholesterol; HOMA‐IR, insulin resistance assessed by homeostasis model assessment; PTH, parathyroid hormone; SBP, systolic blood pressure.

###### 

Relationship between the number of adverse body composition[a](#jcsm12154-note-0011){ref-type="fn"} and subject characteristics in women[b](#jcsm12154-note-0012){ref-type="fn"}

                                                                                     Women (*n* = 3423)                                                      
  ---------------------------------------------------------------------------------- -------------------- ---------------- ---------------- ---------------- ---------
  General characteristics                                                                                                                                    
  Age (y)                                                                            54.2 ± 4.2           62.3 ± 9.0       61.0 ± 8.4       64.2 ± 8.8       \<0.001
  Education level (\>elementary school)                                              66.2                 38.0             41.0             32.4             \<0.001
  Quartiles of equivalent income[d](#jcsm12154-note-0014){ref-type="fn"} (highest)   29.9                 24.2             25.5             28.9             0.08
  Current smoker                                                                     1.4                  6.1              3.1              3.9              \<0.001
  Alcohol consumption (\>1 drinks/d)                                                 7.2                  3.7              3.1              3.0              0.05
  Recommended level of exercise[e](#jcsm12154-note-0015){ref-type="fn"} (yes)        50.7                 39.2             33.8             31.6             \<0.001
  Sunlight exposure (≥5 h/d)                                                         18.0                 27.1             18.4             14.9             \<0.001
  Dietary supplement use (yes)                                                       57.9                 47.7             46.1             47.0             0.03
  Menopause (yes)                                                                    71.8                 94.2             90.0             96.3             \<0.001
  Laboratory data[f](#jcsm12154-note-0016){ref-type="fn"}                                                                                                    
  SBP (mmHg)                                                                         120.9 ± 18.5         124.3 ± 18.0     125.1 ± 17.7     128.4 ± 18.0     \<0.001
  DBP (mmHg)                                                                         77.0 ± 11.5          75.6 ± 10.0      77.2 ± 9.9       77.5 ± 9.6       0.001
  FBS (mg/dL)                                                                        98.3 ± 22.3          100.5 ± 24.9     101.3 ± 22.0     104.2 ± 25.4     0.02
  HOMA‐IR                                                                            2.4 ± 1.3            2.4 ± 1.6        2.8 ± 2.0        3.1 ± 3.3        \<0.001
  Total cholesterol (mg/dL)                                                          196.5 ± 37.0         199.0 ± 35.3     200.9 ± 36.5     207.8 ± 36.6     \<0.001
  HDL‐C (mg/dL)                                                                      51.1 ± 10.9          48.4 ± 11.2      48.1 ± 10.9      47.4 ± 10.3      \<0.001
  Triglyceride (mg/dL)                                                               124.8 ± 88.3         134.6 ± 87.5     139.9 ± 84.6     149.2 ± 84.8     0.002
  AST (IU/L)                                                                         21.8 ± 6.9           22.8 ± 8.6       23.4 ± 11.1      23.3 ± 9.3       0.06
  ALT (IU/L)                                                                         19.9 ± 10.2          19.5 ± 11.6      20.8 ± 13.4      21.2 ± 11.6      0.02
  Creatinine (mg/dL)                                                                 0.7 ± 0.1            0.7 ± 0.2        0.7 ± 0.2        0.7 ± 0.1        0.21
  PTH (pg/mL)                                                                        61.4 ± 24.3          66.6 ± 32.3      67.2 ± 26.4      73.4 ± 31.6      \<0.001
  Frequency of food group consumption                                                                                                                        
  Meats (times/wk)                                                                   1.4 ± 1.7            1.1 ± 1.4        1.2 ± 1.3        1.2 ± 1.6        0.13
  Egg (times/wk)                                                                     2.0 ± 1.8            1.7 ± 1.9        1.8 ± 1.8        1.6 ± 2.0        0.14
  Fish (times/wk)                                                                    5.1 ± 4.1            4.5 ± 4.2        4.5 ± 4.0        4.1 ± 3.8        0.02
  Mushrooms (times/wk)                                                               1.5 ± 2.0            1.1 ± 1.5        1.1 ± 1.3        1.1 ± 1.3        0.002
  Milk (times/wk)                                                                    2.8 ± 3.3            2.2 ± 3.0        2.1 ± 2.9        1.8 ± 2.7        0.001
  Nutrient intake                                                                                                                                            
  Energy (kcal/d)                                                                    1620.3 ± 566.4       1591.1 ± 531.6   1587.1 ± 535.9   1499.2 ± 528.6   0.01
  Protein (g/d)                                                                      57.1 ± 27.8          52.2 ± 23.8      55.2 ± 25.1      51.2 ± 25.0      0.006
  Calcium (mg/d)                                                                     477.8 ± 321.3        427.8 ± 297.6    440.8 ± 315.5    427.5 ± 598.3    0.17

Multiple adverse body composition: number of osteopenia/osteoporosis, muscle mass loss, or obesity.

Values are mean ± SD, or percentage.

Analysis of variance (ANOVA) for continuous variables and chi‐square test for categorical variables.

Monthly household income/√number of household members according to sex and 5‐year age group.

≥150 min/wk moderate‐intensity and/or ≥ 75 min/wk vigorous‐intensity aerobic physical activity.

ALT, alanine aminotransferase; AST, aspartate aminotransferase; DBP, diastolic blood pressure; FBS, fasting blood sugar; HDL‐C, high density lipoprotein cholesterol; HOMA‐IR, insulin resistance assessed by homeostasis model assessment; PTH, parathyroid hormone; SBP, systolic blood pressure.

The association between 25(OH)D levels and the number of adverse body composition is displayed in *Table* [4](#jcsm12154-tbl-0004){ref-type="table-wrap"}. In men, vitamin D serum levels were inversely associated with higher number of adverse body composition. After controlling for covariates, men in the higher tertiles of serum vitamin D levels, compared with those in the lowest tertile, had a significantly reduced likelihood of multiple adverse body composition (*P* for trend \< 0.05 for those with one, two, or three simultaneous adverse components). Those in the highest tertile exhibited a 58% reduced odds of osteosarcopenic obesity (OR = 0.42, 95% CI: 0.26, 0.67). In women, those in the highest tertile of serum 25(OH)D levels, compared with those in the lowest tertile, were significantly less likely to have osteosarcopenic obesity (OR = 0.55, 95% CI: 0.33, 0.93).

###### 

Likelihood of multiple adverse body composition according to serum vitamin D levels: multinomial logistic regression analysis

            Men (*n* = 2485)                                                      
  --------- ------------------- ------------------- --------- ------------------- ---------
  1 vs. 0   T1 (median, 14.6)   1.00                0.08      1.00                0.02
            T2 (median, 21.1)   0.65 (0.48, 0.89)             0.62 (0.45, 0.87)   
            T3 (median, 29.0)   0.75 (0.56, 1.01)             0.67 (0.49, 0.92)   
  2 vs. 0   T1                  1.00                \<0.001   1.00                \<0.001
            T2                  0.60 (0.42, 0.87)             0.65 (0.44, 0.96)   
            T3                  0.45 (0.31, 0.65)             0.49 (0.33, 0.73)   
  3 vs. 0   T1                  1.00                \<0.001   1.00                \<0.001
            T2                  0.40 (0.27, 0.59)             0.46 (0.30, 0.70)   
            T3                  0.35 (0.23, 0.54)             0.42 (0.26, 0.67)   

            Women (*n* = 3423)                                                  
  --------- -------------------- ------------------- ------ ------------------- ------
  1 vs. 0   T1 (median, 12.2)    1.00                0.63   1.00                0.47
            T2 (median, 18.0)    1.08 (0.75, 1.56)          1.18 (0.79, 1.77)   
            T3 (median, 26.1)    1.10 (0.75, 1.62)          0.86 (0.55, 1.35)   
  2 vs. 0   T1                   1.00                0.6    1.00                0.39
            T2                   0.91 (0.60, 1.38)          1.02 (0.65, 1.59)   
            T3                   0.89 (0.58, 1.37)          0.81 (0.50, 1.32)   
  3 vs. 0   T1                   1.00                0.02   1.00                0.03
            T2                   0.85 (0.57, 1.27)          1.03 (0.66, 1.60)   
  　        T3                   0.58 (0.37, 0.91)          0.55 (0.33, 0.93)   

Number of osteopenia/osteoporosis, muscle mass loss, and obesity.

Adjusted for age, education level, quartiles of equivalent income, smoking, alcohol consumption, recommended level of exercise, sunlight exposure, dietary supplement use, fasting blood sugar, insulin resistance assessed by homeostasis model assessment, high density lipoprotein cholesterol, triglyceride, alanine aminotransferase, creatinine, parathyroid hormone, frequency of food group consumption (meats, egg, fish, mushrooms, milk), and nutrient intake (energy, protein, calcium).

Adjusted for age, education level, quartiles of equivalent income, smoking, alcohol consumption, recommended level of exercise, sunlight exposure, dietary supplement use, menopausal status, systolic blood pressure, diastolic blood pressure, triglyceride, parathyroid hormone, frequency of food group consumption (meats, egg, fish, mushrooms, milk), and nutrient intake (energy, protein, calcium).

The association between vitamin D deficiency and the number of adverse body composition is shown in *Table* [5](#jcsm12154-tbl-0005){ref-type="table-wrap"}. In men, vitamin D deficiency was significantly associated with an increased likelihood of multiple adverse body composition, adjusting for covariates, especially for osteosarcopenic obesity (OR = 2.08, 95% CI: 1.42, 3.03). In women, vitamin D deficiency was significantly associated with osteosarcopenic obesity (OR = 1.99, 95% CI: 1.30, 3.05).

###### 

Likelihood of multiple adverse body composition by the presence of vitamin D deficiency: multinomial logistic regression analysis

            Men (*n* = 2485)                       
  --------- ------------------ ------------------- -------------------
  1 vs. 0   No                 1.00                1.00
            Yes                1.29 (1.00, 1.67)   1.35 (1.03, 1.77)
  2 vs. 0   No                 1.00                1.00
            Yes                1.91 (1.40, 2.61)   1.71 (1.21, 2.41)
  3 vs. 0   No                 1.00                1.00
            Yes                2.52 (1.78, 3.57)   2.08 (1.42, 3.03)

            Women (*n* = 3423)                       
  --------- -------------------- ------------------- -------------------
  1 vs. 0   No                   1.00                1.00
            Yes                  0.99 (0.71, 1.37)   1.31 (0.90, 1.90)
  2 vs. 0   No                   1.00                1.00
            Yes                  1.05 (0.73, 1.52)   1.22 (0.82, 1.82)
  3 vs. 0   No                   1.00                1.00
            Yes                  1.71 (1.17, 2.51)   1.99 (1.30, 3.05)

Number of osteopenia/osteoporosis, muscle mass loss, and obesity.

Adjusted for age, education level, quartiles of equivalent income, smoking, alcohol consumption, recommended level of exercise, sunlight exposure, dietary supplement use, fasting blood sugar, insulin resistance assessed by homeostasis model assessment, high density lipoprotein cholesterol, triglyceride, alanine aminotransferase, creatinine, parathyroid hormone, frequency of food group consumption (meats, egg, fish, mushrooms, milk), and nutrient intake (energy, protein, calcium).

Adjusted for age, education level, quartiles of equivalent income, smoking, alcohol consumption, recommended level of exercise, sunlight exposure, dietary supplement use, menopausal status, systolic blood pressure, diastolic blood pressure, triglyceride, parathyroid hormone, frequency of food group consumption (meats, egg, fish, mushrooms, milk), and nutrient intake (energy, protein, calcium).

Discussion {#jcsm12154-sec-0012}
==========

Serum vitamin D levels were significantly associated with multiple adverse body composition in middle‐aged and older Korean adults. After adjusting for covariates, in men, higher serum vitamin D levels were negatively associated, while deficiency of serum vitamin D was positively associated, with the number of abnormal body composition. In women, higher serum vitamin D levels were negatively associated with osteosarcopenic obesity and deficiency of serum vitamin D was positively associated with osteosarcopenic obesity. To our knowledge, this is the first study to demonstrate the significant association between serum vitamin D levels and multiple adverse body composition in community‐dwelling people in their mid‐ and late‐life.

Numerous studies have investigated the relationship between serum 25(OH)D levels and individual body composition. Calcium and vitamin D were positively associated with bone health in several studies.[10](#jcsm12154-bib-0010){ref-type="ref"}, [11](#jcsm12154-bib-0011){ref-type="ref"}, [12](#jcsm12154-bib-0012){ref-type="ref"}, [13](#jcsm12154-bib-0013){ref-type="ref"}, [14](#jcsm12154-bib-0014){ref-type="ref"} A study involving a nationwide sample of Koreans aged 40 years and older showed a lower mean value of appendicular skeletal muscle mass index (ASSMI) in men, but not in women, with hypovitaminosis, defined as serum 25(OH)D \< 20 ng/mL.[15](#jcsm12154-bib-0015){ref-type="ref"} An inverse relationship between body fat percentage (BF) and serum 25(OH)D or vitamin D deficiency, irrespective of the fat location, has also been reported.[16](#jcsm12154-bib-0016){ref-type="ref"}

However, relatively few studies have examined the relationship between serum vitamin D levels and combined indices of body composition. Favourable effects of vitamin D on the interaction between bone and muscle have been suggested.[20](#jcsm12154-bib-0020){ref-type="ref"}, [21](#jcsm12154-bib-0021){ref-type="ref"} In Korean men, those in the combined group with the highest third of total fat percentage (TFP) and the lowest third of total lean mass (TLM), compared with those in the lowest tertile of TFP and highest tertile of total TLM, were 2.2 times more likely to exhibit vitamin D deficiency.[22](#jcsm12154-bib-0022){ref-type="ref"} In a study of Thai populations without diabetes, vitamin D status and male sex were identified as significant positive predictors of percent skeletal muscle mass.[23](#jcsm12154-bib-0023){ref-type="ref"} In lifestyle intervention therapies for obese older adults, vitamin D supplementation is recommended when inducing weight loss, for minimizing bone and muscle mass loss.[34](#jcsm12154-bib-0034){ref-type="ref"}

The potential roles of vitamin D in bone, muscle, and body fat have been suggested. Vitamin D is known to have beneficial effects on the bone by suppressing PTH levels and promoting calcium absorption, and further lowering the risk of falls and fracture.[7](#jcsm12154-bib-0007){ref-type="ref"}, [17](#jcsm12154-bib-0017){ref-type="ref"} Vitamin D, in its active form, can stimulate muscle cell proliferation and growth by activating vitamin D receptors (VDR) that mediates both gene transcription and rapid non‐transcriptional signal transduction, regulating protein synthesis and calcium handling involved in muscle cell development.[35](#jcsm12154-bib-0035){ref-type="ref"} In body fat, vitamin D may modulate VDR that can affect energy metabolism[19](#jcsm12154-bib-0019){ref-type="ref"} and also potentially modulate adipogenesis and preadipocyte differentiation.[8](#jcsm12154-bib-0008){ref-type="ref"} Vitamin D deficiency might induce adipogenesis, whereas higher vitamin D concentration attenuates the effect.[36](#jcsm12154-bib-0036){ref-type="ref"} Alternatively, obesity may be a risk factor for vitamin D deficiency.[37](#jcsm12154-bib-0037){ref-type="ref"} Anti‐inflammatory effects of vitamin D have been suggested as well.[38](#jcsm12154-bib-0038){ref-type="ref"} Vitamin D may mediate bone--muscle cross‐talk. It inhibits myostatin production, while stimulating vascular endothelial growth factor, insulin‐like growth factor‐1, and osteoglycin production in muscle that have beneficial effects on bone.[5](#jcsm12154-bib-0005){ref-type="ref"} Alternatively, vitamin D may increase the production of sclerostin, osteocalcin, and fibroblast growth factor‐23 in bone that can potentially stimulate myogenic activity.

In this study, the magnitude of the association between serum 25(OH)D levels and multiple adverse body composition was stronger in men than women. This gender difference could be because of in part the effect of the genotype of VDR (FokI) polymorphism, the risk allele (F allele), found in older men that increases the risk of sarcopenia.[39](#jcsm12154-bib-0039){ref-type="ref"} More men than women may have the risk allele, leading to a more rapid decline in skeletal muscle mass. Also, vitamin D co‐regulates the synthesis of sex hormones,[40](#jcsm12154-bib-0040){ref-type="ref"} with adverse skeletal effects of low sex steroid levels being pronounced among men with low 25(OH)D levels.[41](#jcsm12154-bib-0041){ref-type="ref"} Further study is needed to confirm the gender difference.

The strength of this study lies in the representativeness of the study sample, giving credence to the external validity of the results. Moreover, numerous potential confounders were adjusted in the analysis, demonstrating the robustness of the findings.

In interpreting the results of this study, however, several limitations need to be considered. First, data on the seasonal variation of exposure to solar ultraviolet‐B radiation and diets enriched with vitamin D, including supplements, that could modify 25(OH)D blood levels were not available for analysis. Second, sarcopenia was defined by muscle mass loss only, because muscle performance was not assessed in the survey. Third, the association of vitamin D with mutually exclusive combinations of abnormal body composition could not be analysed because of insufficient sample size. Finally, the cross‐sectional design of the survey prevents us from making any causal inferences of vitamin D\'s possible effect on multiple adverse body composition. A reverse causality cannot be ruled out, as vitamin D may be sequestered in adipose tissues of obese individuals.[37](#jcsm12154-bib-0037){ref-type="ref"}

In conclusion, we found that higher serum vitamin D levels were associated with a reduced likelihood of concurrent adverse body composition in middle‐aged and older adults, with a deficiency of serum vitamin D being associated with an elevated risk. Our findings suggest that maintaining serum vitamin D levels may potentially protect against combined abnormalities in body composition, especially osteosarcopenic obesity, in midlife and late life. Longitudinal studies are warranted to better understand whether differences in serum vitamin D levels affect multiple components of body composition.
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